Based on the findings, we first discovered that HNF4G promotes MAPK6 expression and subsequent Akt phosphorylation by binding to the MAPK6 promoter region, resulting in cisplatin resistance in lung adenocarcinoma. The gene discussed is MAPK6; the disease is lung adenocarcinoma.